Subscribe To
5 large drug stocks to watch as sector picks up in 2023
Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap pharmace...
March 9, 2023, 9:11 am
Ani pharmaceuticals (anip) q4 earnings and revenues top estimates
ANI (ANIP) delivered earnings and revenue surprises of 11.76% and 8.62%, respectively, for the quarter ended December 2022. Do the numbers hold clues ...
March 9, 2023, 9:11 am
Immunome to present at 13th annual world adc london conference
EXTON, Pa.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes i...
March 9, 2023, 8:45 am
Zymeworks offers hope for more than just long-term investors
Zymeworks Inc. (NASDAQ: ZYME) stock is up almost 5% after beating analysts' expectations for revenue and earnings in its March 7, 2023 earnings report...
March 9, 2023, 6:46 am
Cassava sciences stock price outlook is bearish despite insider buy
Cassava Sciences (NASDAQ: SAVA) stock price has been in a steep sell-off in the past few months as the enthusiasm of its pipeline wanes. Shares of the...
March 9, 2023, 1:39 am
Mirum pharmaceuticals, inc. (mirm) q4 2022 earnings call transcript
Mirum pharmaceuticals, Inc. (MIRM) Q4 2022 Earnings Conference Call March 8, 2023 4:30 PM ET Corporate ...
March 8, 2023, 10:40 pm
Macrogenics announces sale of tzield™ royalty interest for up to $200 million
ROCKVILLE, MD, March 08, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical...
March 8, 2023, 10:36 pm
Quoin pharmaceuticals provides corporate update and announces fourth quarter and full year 2022 financial results
Quoin announced dosing of first patient in double blinded clinical study to evaluate QRX003 for Netherton Syndrome Quoin announced initiation of a sec...
March 8, 2023, 10:08 pm
Springworks therapeutics announces new england journal of medicine publication of phase 3 defi trial evaluating nirogacestat in adults with desmoid tumors
– Nirogacestat Treatment Significantly Improved Progression-Free Survival, Objective Response Rate and Key Patient Reported Outcomes – – New Dru...
March 8, 2023, 10:05 pm
Mirum pharmaceuticals, inc. (mirm) reports q4 loss, tops revenue estimates
Mirum pharmaceuticals, Inc. (MIRM) delivered earnings and revenue surprises of -1.02% and 11.69%, respe...
March 8, 2023, 9:49 pm
Clene to announce new cnm-au8® data from the healey als platform trial
Webcast set for 7:30 a.m. ET on March 9 SALT LAKE CITY, March 08, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, �...
March 8, 2023, 9:10 pm
Tracon pharmaceuticals, inc. (tcon) q4 2022 earnings call transcript
TRACON pharmaceuticals, Inc. (NASDAQ:TCON ) Q4 2022 Earnings Conference Call March 8, 2023 4:30 PM ET C...
March 8, 2023, 8:00 pm
Kala pharmaceuticals to present at the oppenheimer 33rd annual healthcare conference
ARLINGTON, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Kala pharmaceuticals, Inc. (NASDAQ:KALA), a clinic...
March 8, 2023, 4:01 pm
Biocryst: good candidate for buyout, but not for anything else
BioCryst pharmaceuticals, Inc. has one blockbuster potential marketed drug, but not much of a pipeline....
March 8, 2023, 2:01 pm
Is amphastar pharmaceuticals (amph) stock outpacing its medical peers this year?
Here is how Amphastar pharmaceuticals (AMPH) and Annovis Bio, Inc. (ANVS) have performed compared to th...
March 8, 2023, 11:17 am
Enanta pharmaceuticals to present new data for edp-235, its 3cl protease inhibitor, in development as an oral, once-daily treatment for covid-19, at the 36th international conference on antiviral rese
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta pharmaceuticals, Inc....
March 8, 2023, 8:51 am
Enanta pharmaceuticals to present new data for edp-235, its 3cl protease inhibitor, in development as an oral, once-daily treatment for covid-19, at the 36th international conference on antiviral rese
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta pharmaceuticals, Inc....
March 8, 2023, 8:51 am
Paratek pharmaceuticals to report fourth quarter and full year 2022 financial results on march 16
BOSTON, March 08, 2023 (GLOBE NEWSWIRE) -- Paratek pharmaceuticals, Inc. (Nasdaq: PRTK) today announced...
March 8, 2023, 8:30 am
2 no-brainer growth stocks to buy right now
Vertex pharmaceuticals is a highly profitable and rapidly growing business with serious untapped potent...
March 8, 2023, 5:57 am
Rigel pharmaceuticals, inc. (rigl) q4 2022 earnings call transcript
Rigel pharmaceuticals, Inc. (NASDAQ:RIGL ) Q4 2022 Earnings Conference Call March 7, 2023 4:30 PM ET Co...
March 7, 2023, 11:45 pm